| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 Jan 25 | NEPH Nephros | Stock Option Common Stock | Grant | Acquire A | No | No | 1.47 | 7,050 | 10.36 k | 7,050 |
| 14 May 24 | NEPH Nephros | Stock Option Common Stock | Grant | Acquire A | No | No | 2.14 | 7,323 | 15.67 k | 7,323 |
| 13 Dec 23 | NEPH Nephros | Common Stock | Grant | Acquire A | No | No | 0 | 9,291 | 0.00 | 48,629 |
| 10 Aug 23 | RVLPQ RVL Pharmaceuticals | Ordinary Shares | Payment of exercise | Dispose F | No | No | 0.49 | 12,000 | 5.88 k | 112,557 |
